tiprankstipranks
Trending News
More News >
Astellas Pharma (JP:4503)
:4503

Astellas Pharma (4503) Revenue

Compare
4 Followers

Astellas Pharma Revenue

Astellas Pharma had a revenue of 524.32B in the quarter ending Sep 30, 2025, with 3.66%. This bring the company's revenue in the last twelve months to 2.01T, Decreased 3.18%. In the fiscal year ending Dec 31, 2025, Astellas Pharma had annual revenue of 1.91T with 19.25% growth.
Revenue (ttm)
2.01T
Revenue Growth
13.24%
P/S Ratio
2.00
Revenue/Employee
¥129,613,867
Employees
14,754
Market Cap
¥3.83T

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
1.91T308.65B+119.25%
Dec 31, 2024
1.60T85.05B+105.60%
Dec 31, 2023
1.52T222.46B+117.16%
Dec 31, 2022
1.30T46.63B+103.73%
Dec 31, 2021
1.25T-51.31B+96.06%
Dec 31, 2020
1.30T-5.50B+99.58%
Dec 31, 2018
1.31T6.03B+100.46%
Dec 31, 2017
1.30T-11.35B+99.13%
Dec 31, 2016
1.31T